Verrica VP-102-102: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 years and older) wit

Project: Research project

Project Details

StatusActive
Effective start/end date9/29/174/25/21

Funding

  • Northwestern University
  • Verrica Pharmaceuticals